查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1469122

照護端診斷市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、平台、購買方式、最終用戶、地區和競爭細分，2019-2029F

Point of Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Platform, By Mode Of Purchase, By End User, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年，全球照護端診斷市場估值為431.2 億美元，預計在預測期內將強勁成長，到2029 年複合年成長率為9.18%。轉型，反映了人們對分散式快速診斷解決方案的日益重視。在技​​術進步和對即時現場醫療結果的需求的推動下，這個市場涵蓋了一系列專為在患者所在地或附近使用而設計的診斷設備。照護端診斷在提供及時且可操作的資訊方面發揮著至關重要的作用，特別是在傳統實驗室測試可能不切實際或耗時的環境中。該市場包括多種產品，如血糖儀、懷孕測試、傳染病測試、心臟標記等。慢性病的日益流行，加上對快速且高效診斷工具的需求，推動了各種醫療機構採用即時檢測。推動市場擴張的關鍵因素包括人們對早期疾病檢測益處的認知不斷增強、全球傳染病負擔不斷增加以及個人化醫療的趨勢不斷成長。 COVID-19 大流行進一步加速了對快速診斷解決方案的需求，凸顯了即時診斷在管理公共衛生危機中的關鍵作用。生物感測器的整合、設備的小型化以及方便用戶使用介面的開發等技術進步提高了即時診斷設備的性能和可訪問性。

主要市場促進因素

慢性病盛行率上升

對立即結果和現場測試的需求

照護端設備的技術進步

主要市場挑戰

監管障礙和標準化

品質和準確性問題

主要市場趨勢

數位健康科技的整合

生物感測器技術的快速進步

細分市場洞察

產品洞察

平台洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球照護端診斷市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 依產品（血糖監測產品、心臟代謝監測產品、傳染病檢測產品、凝血監測產品、Covid-19 檢測產品、其他）
    • 依平台（側流分析、試紙、微流體、分子診斷、免疫分析）
    • 按購買方式（處方產品、非處方藥產品）
    • 按最終使用者（醫院診所、門診手術中心、其他）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖
    • 按產品分類
    • 按平台
    • 按購買方式
    • 按最終用戶
    • 按地區

第 5 章：亞太地區照護端診斷市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按產品分類
    • 按平台
    • 按購買方式
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第 6 章：歐洲照護端診斷市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按產品分類
    • 按平台
    • 按購買方式
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美照護端診斷市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按產品分類
    • 按平台
    • 按購買方式
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美洲照護端診斷市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按產品分類
    • 按平台
    • 按購買方式
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲照護端診斷市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按產品分類
    • 按平台
    • 按購買方式
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 埃及

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢發展

  • 最近的發展
  • 產品發布
  • 併購

第 12 章：全球照護端診斷市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • EKF Diagnostics
  • Abbott Laboratories Inc.
  • Siemens Healthineers Ag
  • F. Hoffmann-La Roche Ltd
  • Quidel Corporation
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc
  • Biomerieux SA
  • Chembio Diagnostics, Inc.

第 15 章：策略建議

第 16 章：關於我們免責聲明

簡介目錄
Product Code: 23497

Global Point of Care Diagnostics Market was valued at USD 43.12 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 9.18% through 2029. The Global Point of Care Diagnostics Market has witnessed significant growth and transformation in recent years, reflecting the increasing emphasis on decentralized and rapid diagnostic solutions. This market, driven by technological advancements and the demand for immediate and on-site medical results, encompasses a wide array of diagnostic devices designed for use at or near the patient's location. Point of care diagnostics plays a crucial role in delivering timely and actionable information, particularly in settings where traditional laboratory testing may be impractical or time-consuming. The market includes a diverse range of products such as glucose meters, pregnancy tests, infectious disease tests, cardiac markers, and more. The growing prevalence of chronic diseases, coupled with the need for quick and efficient diagnostic tools, has fueled the adoption of point-of-care testing across various healthcare settings. Key factors driving the market's expansion include the increasing awareness of the benefits of early disease detection, the rising global burden of infectious diseases, and the growing trend towards personalized medicine. The COVID-19 pandemic has further accelerated the demand for rapid diagnostic solutions, highlighting the crucial role of point-of-care diagnostics in managing public health crises. Advancements in technology, such as the integration of biosensors, miniaturization of devices, and the development of user-friendly interfaces, have enhanced the performance and accessibility of point-of-care diagnostic devices.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases globally stands out as a primary driver propelling the growth of the Global Point of Care Diagnostics Market. Chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders have become increasingly prevalent, posing significant challenges to healthcare systems worldwide. This surge in chronic illnesses has created a pressing need for efficient and timely diagnostic solutions, a demand that point-of-care diagnostics effectively addresses. These diagnostic tools offer the advantage of immediate testing at or near the patient's location, enabling swift detection of biomarkers associated with chronic diseases. By providing rapid results, point-of-care diagnostics facilitate early intervention and contribute to improved management of chronic conditions.

The burden of chronic diseases is particularly pronounced in aging populations, where the risk of developing such conditions is higher. As demographics shift towards an older age structure globally, the demand for point-of-care diagnostics becomes even more pronounced. These diagnostic tools empower healthcare professionals to promptly identify and monitor chronic diseases, allowing for timely adjustments to treatment plans and lifestyle interventions. The ability to obtain real-time information through point-of-care testing enhances the overall efficiency of healthcare delivery, leading to better patient outcomes.

The rising prevalence of chronic diseases is associated with an increased focus on preventive healthcare and early disease detection. Point-of-care diagnostics align perfectly with these objectives, as they enable healthcare providers to conduct immediate testing and deliver prompt results. This proactive approach to healthcare is crucial in managing chronic conditions, where early intervention can significantly impact disease progression and improve the quality of life for patients.

The COVID-19 pandemic has further underscored the importance of rapid diagnostics, amplifying the significance of point-of-care testing in addressing not only infectious diseases but also chronic conditions. As healthcare systems recalibrate their priorities to accommodate the dual challenges of infectious and chronic diseases, the role of point-of-care diagnostics becomes pivotal. The market is witnessing increased investment in research and development to enhance the capabilities of these diagnostic tools, ensuring they meet the evolving demands of a healthcare landscape marked by the rising prevalence of chronic diseases.

Demand for Immediate Results and On-Site Testing

The Global Point of Care Diagnostics Market is experiencing a significant boost driven by the increasing demand for immediate results and on-site testing. In an era where time is a critical factor in healthcare decision-making, the need for swift diagnostic outcomes has become paramount. Point-of-care diagnostics, with its capacity to deliver rapid results directly at the patient's location, addresses this imperative. The demand for immediate results is particularly evident in emergency and critical care settings, where timely diagnosis can be a matter of life and death. Point-of-care testing eliminates the delays associated with transporting samples to centralized laboratories, allowing healthcare providers to make quick and informed decisions, leading to more effective patient management.

The convenience and efficiency of on-site testing are reshaping healthcare delivery across various settings. Hospitals, clinics, and even home care environments are increasingly adopting point-of-care diagnostics to streamline the diagnostic process. Patients benefit from reduced waiting times and quicker access to results, leading to a more seamless healthcare experience. This demand is further fueled by the growing emphasis on patient-centered care, where immediate access to diagnostic information empowers individuals to actively participate in their healthcare decisions.

The urgency for on-site testing has been accentuated by the global response to the COVID-19 pandemic. Point-of-care diagnostics played a pivotal role in the rapid identification of the SARS-CoV-2 virus, enabling swift isolation and treatment of affected individuals. This experience has underscored the critical role of immediate results in managing public health crises, further solidifying the position of point-of-care diagnostics as an indispensable tool in infectious disease control.

Technological advancements have played a crucial role in meeting the demand for on-site testing. The miniaturization of diagnostic devices, coupled with the integration of advanced sensors and user-friendly interfaces, has enhanced the performance and accessibility of point-of-care diagnostics. These innovations have enabled healthcare providers to conduct a broad range of tests rapidly and efficiently at the point of care, contributing to the market's growth.

Technological Advancements in Point-of-Care Devices

Technological advancements in point-of-care devices are playing a pivotal role in boosting the Global Point of Care Diagnostics Market, ushering in a new era of efficiency, accuracy, and accessibility in healthcare diagnostics. Innovations such as biosensors, microfluidics, and miniaturized devices have significantly elevated the capabilities of point-of-care diagnostics, driving market growth. Biosensors, for example, enable the rapid and sensitive detection of specific biomarkers, enhancing the diagnostic accuracy of these devices. The miniaturization of diagnostic tools not only facilitates portability but also contributes to the development of user-friendly, handheld devices that can be easily operated by healthcare professionals in diverse settings.

Microfluidics technology has emerged as a key enabler in point-of-care diagnostics, allowing for precise manipulation of small volumes of fluids within micro-scale channels. This technology enhances the sensitivity and specificity of diagnostic tests while reducing the time required for analysis. The integration of microfluidics into point-of-care devices enables complex assays to be performed with minimal sample volumes, making them well-suited for applications in resource-limited settings and scenarios where rapid results are critical.

The incorporation of connectivity features and smartphone applications has transformed point-of-care devices into powerful tools for data management and remote monitoring. These advancements allow healthcare professionals to seamlessly collect, analyze, and share diagnostic information, facilitating collaborative decision-making and improving patient care. The integration of technology has also extended the reach of point-of-care diagnostics beyond traditional healthcare settings, enabling testing in remote or underserved areas.

The ongoing convergence of biotechnology, nanotechnology, and information technology continues to drive innovation in point-of-care diagnostics. The development of lab-on-a-chip technologies, where entire diagnostic processes are integrated onto a single chip, further enhances the speed and efficiency of point-of-care testing. Such advancements not only streamline diagnostic workflows but also contribute to cost-effectiveness and resource efficiency, making point-of-care diagnostics an attractive option for healthcare providers and institutions.

Key Market Challenges

Regulatory Hurdles and Standardization

The Global Point of Care Diagnostics Market, driven by the demand for rapid and decentralized testing solutions, faces significant obstacles stemming from regulatory hurdles and the lack of standardization. This complex regulatory landscape poses a formidable challenge for manufacturers, hindering the timely introduction of innovative products and impeding the overall growth of the market.

The diversity of point-of-care devices and technologies within the market complicates regulatory efforts, as different regions and countries maintain distinct regulatory frameworks. Varying approval processes, documentation requirements, and compliance standards create a labyrinthine landscape for manufacturers seeking global market access. The absence of harmonized regulations not only delays the introduction of new point-of-care devices but also raises the cost of compliance, impacting both manufacturers and end-users.

Standardization, or the lack thereof, further exacerbates challenges in the Global Point of Care Diagnostics Market. The absence of universally accepted protocols for point-of-care devices poses difficulties for interoperability and data exchange between different diagnostic tools and healthcare information systems. This lack of standardization not only hampers the seamless integration of point-of-care results into electronic health records but also complicates the sharing of information among healthcare professionals, impeding collaborative decision-making.

Quality and Accuracy Concerns

Despite the transformative potential of point-of-care diagnostics in providing rapid and decentralized testing solutions, the Global Point of Care Diagnostics Market faces significant challenges related to concerns about the quality and accuracy of test results. Ensuring the reliability of point-of-care tests is paramount to building trust among healthcare providers, regulators, and patients, yet maintaining stringent quality control measures across diverse settings remains a formidable task.

One of the primary concerns revolves around the consistency and accuracy of point-of-care results compared to traditional laboratory testing. While these diagnostics offer the advantage of immediate testing, questions about the reliability of results persist. Variability in environmental conditions, operator proficiency, and device performance can impact the accuracy of point-of-care tests, raising concerns among healthcare professionals and regulatory authorities.

Robust validation processes and ongoing quality assurance initiatives are essential to address these concerns. Manufacturers must invest in comprehensive testing protocols, ensuring that point-of-care devices consistently meet stringent performance standards. The regulatory bodies play a crucial role in establishing and enforcing quality control measures, creating a framework that fosters confidence in the accuracy of point-of-care diagnostics.

The nature of point-of-care testing, often conducted in diverse and resource-limited settings, introduces additional challenges related to maintaining quality and accuracy. Point-of-care devices may be deployed in environments with varying temperatures, humidity levels, and infrastructure capabilities. Adapting to these conditions without compromising the precision of diagnostic results requires innovative engineering solutions and rigorous testing under real-world conditions.

Key Market Trends

Integration of Digital Health Technologies

The integration of digital health technologies is emerging as a pivotal trend, significantly boosting the Global Point of Care Diagnostics Market. This transformative trend represents the convergence of point-of-care diagnostics with innovative digital platforms, including mobile applications and cloud-based systems. The seamless integration of diagnostics and digital health technologies facilitates real-time data sharing, remote monitoring, and enhanced connectivity between point-of-care devices and electronic health records. This synergy not only streamlines the flow of information but also empowers healthcare providers with timely and actionable insights, ultimately improving patient management.

The incorporation of digital health technologies into point-of-care diagnostics brings about a paradigm shift in healthcare delivery. Mobile applications paired with diagnostic devices allow for more accessible and user-friendly interfaces, empowering both healthcare professionals and patients. Patients can actively participate in their healthcare by receiving immediate results and tracking their health data, fostering a sense of engagement and empowerment. For healthcare providers, the integration enables more efficient and coordinated care, as diagnostic information seamlessly integrates into comprehensive electronic health records.

The connectivity facilitated by digital health technologies supports remote monitoring, enabling healthcare professionals to track patients' health status in real-time, especially relevant in chronic disease management. This trend is particularly crucial in the era of telemedicine and virtual care, where point-of-care diagnostics play a central role in expanding healthcare access beyond traditional settings. The ongoing integration of digital health technologies into point-of-care diagnostics is not only enhancing the efficiency and accessibility of medical testing but also contributing to the overall evolution of healthcare systems.

Rapid Advancements in Biosensor Technology

Rapid advancements in biosensor technology have emerged as a transformative force, catalyzing significant growth in the global point-of-care diagnostics market. Biosensors, which combine biological components with transducers to detect and analyze biological markers, have become integral to the development of innovative diagnostic tools that offer quick and accurate results at the point of care. These technological strides have revolutionized healthcare by providing healthcare professionals and patients with timely information for swift decision-making. The global point-of-care diagnostics market has experienced a substantial boost as biosensors continue to evolve, offering enhanced sensitivity, specificity, and portability.

Biosensors enable the development of handheld, user-friendly devices that can detect a wide range of biomarkers, from glucose levels to infectious diseases, in real-time. This shift towards point-of-care diagnostics not only improves patient outcomes but also streamlines healthcare delivery and reduces the burden on traditional laboratory infrastructure. Biosensor technology has played a pivotal role in the continuous monitoring of chronic conditions, enabling personalized and proactive healthcare. Wearable biosensors can track physiological parameters, such as glucose levels, allowing individuals and healthcare professionals to manage chronic diseases more effectively. The integration of biosensors into connected health ecosystems has created a seamless flow of information, empowering patients to actively participate in their healthcare management.

The global point-of-care diagnostics market has witnessed a surge in investment and research collaborations aimed at developing cutting-edge biosensor technologies. Advancements in materials science, nanotechnology, and biochemistry have contributed to the design of biosensors with improved sensitivity and specificity, expanding the range of detectable analytes. As a result, the market is experiencing a proliferation of novel biosensor-based diagnostic devices across various medical fields, including infectious diseases, cardiovascular health, and cancer diagnostics.

Segmental Insights

Product Insights

Based on the Product, glucose monitoring products emerged as the dominant segment in the global market for Global HematologyPoint of Care Diagnostics in 2023.The high demand for glucose monitoring devices is driven by the increasing prevalence of diabetes worldwide. With the growing incidence of diabetes and the need for regular monitoring of blood glucose levels, point-of-care glucose testing devices have become integral in the management of this chronic condition. These devices offer quick and convenient testing, allowing patients to monitor their glucose levels at home or in various healthcare settings. The demand for glucose monitoring products has been further accelerated by technological advancements, such as continuous glucose monitoring systems, which provide real-time data and reduce the need for traditional fingerstick tests.

Platform Insights

Based on the Platform, Lateral Flow Assays emerged as the dominant segment in the global market for Global Point of Care Diagnostics Market in 2023.Lateral flow assays are known for their simplicity, speed, and ease of use. These assays, often in the form of test strips or cartridges, are designed for rapid on-site detection of various analytes. They are widely used in applications like pregnancy tests, infectious disease testing, and cardiac markers. The simplicity of the lateral flow format makes it suitable for point-of-care settings where rapid results are crucial.

Regional Insights

North America emerged as the dominant player in the Global Point of Care Diagnostics Market in 2023, holding the largest market share. North America has been at the forefront of technological advancements in the healthcare sector, and this includes point-of-care diagnostics. The region has a robust infrastructure supporting research and development activities, leading to the introduction of innovative and advanced diagnostic technologies. The continuous integration of cutting-edge technologies enhances the efficiency and accuracy of point-of-care diagnostics, attracting both healthcare providers and patients. The United States, in particular, has one of the highest healthcare expenditures globally. The significant investment in healthcare infrastructure, research, and development creates an environment conducive to the adoption of advanced medical technologies, including point-of-care diagnostics. The willingness to invest in state-of-the-art healthcare solutions contributes to the dominance of North America in the market.

Key Market Players

EKF Diagnostics

Abbott Laboratories Inc.

Siemens Healthineers Ag

F. Hoffmann-La Roche Ltd

Quidel Corporation

Danaher Corporation

Becton, Dickinson and Company

Thermo Fisher Scientific Inc

Biomerieux S.A.

Chembio Diagnostics, Inc

Report Scope:

In this report, the Global Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Point of Care Diagnostics Market,By Product:

  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring products
  • Covid-19 Test Products
  • Others

Point of Care Diagnostics Market,By Platform:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Point of Care Diagnostics Market,By Mode of Purchase:

  • Prescription Based Products
  • OTC Products

Point of Care Diagnostics Market,By End User:

  • Hospitals Clinics
  • Ambulatory Surgical Centers
  • Others

Point of Care Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Point of Care Diagnostics Market.

Available Customizations:

Global Point of Care Diagnostics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Point of Care Diagnostics Market Outlook

  • 4.1.Market Size Forecast
    • 4.1.1.By Value
  • 4.2.Market Share Forecast
    • 4.2.1.By Product (Glucose Monitoring Products, Cardiometabolic Monitoring Products, infectious Disease Testing Products, Coagulation Monitoring products, Covid-19 Test Products, Others)
    • 4.2.2.By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays)
    • 4.2.3.By Mode Of Purchase (Prescription Based Products, OTC Products)
    • 4.2.4.By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others)
    • 4.2.5.By Region
    • 4.2.6.By Company (2023)
  • 4.3.Market Map
    • 4.3.1.By Product
    • 4.3.2.By Platform
    • 4.3.3.By Mode Of Purchase
    • 4.3.4.By End User
    • 4.3.5.By Region

5.Asia Pacific Point of Care Diagnostics Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Product
    • 5.2.2.By Platform
    • 5.2.3.By Mode Of Purchase
    • 5.2.4.By End User
    • 5.2.5.By Country
  • 5.3.Asia Pacific: Country Analysis
    • 5.3.1.China Point of Care Diagnostics Market Outlook
      • 5.3.1.1.Market Size Forecast
        • 5.3.1.1.1.By Value
      • 5.3.1.2.Market Share Forecast
        • 5.3.1.2.1.By Product
        • 5.3.1.2.2.By Platform
        • 5.3.1.2.3.By Mode Of Purchase
        • 5.3.1.2.4.By End User
    • 5.3.2.India Point of Care Diagnostics Market Outlook
      • 5.3.2.1.Market Size Forecast
        • 5.3.2.1.1.By Value
      • 5.3.2.2.Market Share Forecast
        • 5.3.2.2.1.By Product
        • 5.3.2.2.2.By Platform
        • 5.3.2.2.3.By Mode Of Purchase
        • 5.3.2.2.4.By End User
    • 5.3.3.Australia Point of Care Diagnostics Market Outlook
      • 5.3.3.1.Market Size Forecast
        • 5.3.3.1.1.By Value
      • 5.3.3.2.Market Share Forecast
        • 5.3.3.2.1.By Product
        • 5.3.3.2.2.By Platform
        • 5.3.3.2.3.By Mode Of Purchase
        • 5.3.3.2.4.By End User
    • 5.3.4.Japan Point of Care Diagnostics Market Outlook
      • 5.3.4.1.Market Size Forecast
        • 5.3.4.1.1.By Value
      • 5.3.4.2.Market Share Forecast
        • 5.3.4.2.1.By Product
        • 5.3.4.2.2.By Platform
        • 5.3.4.2.3.By Mode Of Purchase
        • 5.3.4.2.4.By End User
    • 5.3.5.South Korea Point of Care Diagnostics Market Outlook
      • 5.3.5.1.Market Size Forecast
        • 5.3.5.1.1.By Value
      • 5.3.5.2.Market Share Forecast
        • 5.3.5.2.1.By Product
        • 5.3.5.2.2.By Platform
        • 5.3.5.2.3.By Mode Of Purchase
        • 5.3.5.2.4.By End User

6.Europe Point of Care Diagnostics Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Product
    • 6.2.2.By Platform
    • 6.2.3.By Mode Of Purchase
    • 6.2.4.By End User
    • 6.2.5.By Country
  • 6.3.Europe: Country Analysis
    • 6.3.1.France Point of Care Diagnostics Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Product
        • 6.3.1.2.2.By Platform
        • 6.3.1.2.3.By Mode Of Purchase
        • 6.3.1.2.4.By End User
    • 6.3.2.Germany Point of Care Diagnostics Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Product
        • 6.3.2.2.2.By Platform
        • 6.3.2.2.3.By Mode Of Purchase
        • 6.3.2.2.4.By End User
    • 6.3.3.Spain Point of Care Diagnostics Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Product
        • 6.3.3.2.2.By Platform
        • 6.3.3.2.3.By Mode Of Purchase
        • 6.3.3.2.4.By End User
    • 6.3.4.Italy Point of Care Diagnostics Market Outlook
      • 6.3.4.1.Market Size Forecast
        • 6.3.4.1.1.By Value
      • 6.3.4.2.Market Share Forecast
        • 6.3.4.2.1.By Product
        • 6.3.4.2.2.By Platform
        • 6.3.4.2.3.By Mode Of Purchase
        • 6.3.4.2.4.By End User
    • 6.3.5.United Kingdom Point of Care Diagnostics Market Outlook
      • 6.3.5.1.Market Size Forecast
        • 6.3.5.1.1.By Value
      • 6.3.5.2.Market Share Forecast
        • 6.3.5.2.1.By Product
        • 6.3.5.2.2.By Platform
        • 6.3.5.2.3.By Mode Of Purchase
        • 6.3.5.2.4.By End User

7.North America Point of Care Diagnostics Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Product
    • 7.2.2.By Platform
    • 7.2.3.By Mode Of Purchase
    • 7.2.4.By End User
    • 7.2.5.By Country
  • 7.3.North America: Country Analysis
    • 7.3.1.United States Point of Care Diagnostics Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Product
        • 7.3.1.2.2.By Platform
        • 7.3.1.2.3.By Mode Of Purchase
        • 7.3.1.2.4.By End User
    • 7.3.2.Mexico Point of Care Diagnostics Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Product
        • 7.3.2.2.2.By Platform
        • 7.3.2.2.3.By Mode Of Purchase
        • 7.3.2.2.4.By End User
    • 7.3.3.Canada Point of Care Diagnostics Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Product
        • 7.3.3.2.2.By Platform
        • 7.3.3.2.3.By Mode Of Purchase
        • 7.3.3.2.4.By End User

8.South America Point of Care Diagnostics Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Product
    • 8.2.2.By Platform
    • 8.2.3.By Mode Of Purchase
    • 8.2.4.By End User
    • 8.2.5.By Country
  • 8.3.South America: Country Analysis
    • 8.3.1.Brazil Point of Care Diagnostics Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Product
        • 8.3.1.2.2.By Platform
        • 8.3.1.2.3.By Mode Of Purchase
        • 8.3.1.2.4.By End User
    • 8.3.2.Argentina Point of Care Diagnostics Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Product
        • 8.3.2.2.2.By Platform
        • 8.3.2.2.3.By Mode Of Purchase
        • 8.3.2.2.4.By End User
    • 8.3.3.Colombia Point of Care Diagnostics Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Product
        • 8.3.3.2.2.By Platform
        • 8.3.3.2.3.By Mode Of Purchase
        • 8.3.3.2.4.By End User

9.Middle East and Africa Point of Care Diagnostics Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Product
    • 9.2.2.By Platform
    • 9.2.3.By Mode Of Purchase
    • 9.2.4.By End User
    • 9.2.5.By Country
  • 9.3.MEA: Country Analysis
    • 9.3.1.South Africa Point of Care Diagnostics Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Product
        • 9.3.1.2.2.By Platform
        • 9.3.1.2.3.By Mode Of Purchase
        • 9.3.1.2.4.By End User
    • 9.3.2.Saudi Arabia Point of Care Diagnostics Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Product
        • 9.3.2.2.2.By Platform
        • 9.3.2.2.3.By Mode Of Purchase
        • 9.3.2.2.4.By End User
    • 9.3.3.UAE Point of Care Diagnostics Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Product
        • 9.3.3.2.2.By Platform
        • 9.3.3.2.3.By Mode Of Purchase
        • 9.3.3.2.4.By End User
    • 9.3.4.Egypt Point of Care Diagnostics Market Outlook
      • 9.3.4.1.Market Size Forecast
        • 9.3.4.1.1.By Value
      • 9.3.4.2.Market Share Forecast
        • 9.3.4.2.1.By Product
        • 9.3.4.2.2.By Platform
        • 9.3.4.2.3.By Mode Of Purchase
        • 9.3.4.2.4.By End User

10.Market Dynamics

  • 10.1.Drivers
  • 10.2.Challenges

11.Market Trends Developments

  • 11.1.Recent Developments
  • 11.2.Product Launches
  • 11.3.Mergers Acquisitions

12.Global Point of Care Diagnostics Market: SWOT Analysis

13.Porter's Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Product

14.Competitive Landscape

  • 14.1.EKF Diagnostics
    • 14.1.1.Business Overview
    • 14.1.2.Company Snapshot
    • 14.1.3.Products Services
    • 14.1.4.Financials (In case of listed)
    • 14.1.5.Recent Developments
    • 14.1.6.SWOT Analysis
  • 14.2.Abbott Laboratories Inc.
  • 14.3.Siemens Healthineers Ag
  • 14.4.F. Hoffmann-La Roche Ltd
  • 14.5.Quidel Corporation
  • 14.6.Danaher Corporation
  • 14.7.Becton, Dickinson and Company
  • 14.8.Thermo Fisher Scientific Inc
  • 14.9.Biomerieux S.A.
  • 14.10.Chembio Diagnostics, Inc.

15.Strategic Recommendations

16. About Us Disclaimer